---
title: "EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/297909579.md"
description: "Modular Medical (NASDAQ: MODD) received FDA clearance for software enhancements to its Pivot insulin delivery system, ahead of the planned Q4 launch. The upgrades offer greater flexibility in bolus dosing and an improved user interface. CEO Jeb Besser expressed satisfaction with the early approval. This follows the initiation of commercial rollout phases in select US markets starting October 2026, supported by partner Inizio. Following the announcement, MODD shares rose 6.94% to $3.70 in premarket trading."
datetime: "2026-09-03T11:33:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/297909579.md)
  - [en](https://longbridge.com/en/news/297909579.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/297909579.md)
generator: "portal-rs"
---

# EXCLUSIVE: Modular Medical Secures FDA Clearance for Pivot Software Upgrades

**Modular Medical, Inc.** (NASDAQ:MODD) on Thursday announced that the U.S. Food & Drug Administration (FDA) has cleared a set of software enhancements to its Pivot insulin delivery system.

The update further expands the system’s functionality and provides users with greater flexibility and customization options in bolus dosing, an enhanced user interface (UI), and other software upgrades. 

In July, the company submitted to the FDA a series of software enhancements to its Pivot insulin delivery system, providing users with more customization options and UI improvements, as well as other software upgrades.

 **Read Also: EXCLUSIVE: Modular Medical Advances Commercial Rollout With First Active Users Of Pivot Insulin Pump** 

"We are pleased that this clearance was received in advance of our planned fourth quarter launch. The cleared improvements represent the first in a series of enhancements and upgrades to the Pivot platform and were designed to expand the functionality and flexibility of Pivot for users, including the ability to customize the amount of insulin delivered with each button push," said Jeb Besser, CEO of Modular Medical.

In August, Modular Medical initiated the first phase of commercialization of its Pivot tubeless patch pump across five strategically selected U.S. markets beginning in October 2026.

To support the launch, Modular Medical partnered with Inizio, a global commercialization partner.

**MODD Stock Price Activity**: Modular Medical shares were up 6.94% at $3.70 during premarket trading Thursday, according to Benzinga Pro data.

 **Read Also: Jeff Bezos' Blue Origin Wins NASA's $700M Mars Contract — Beats Rocket Lab in High-Stakes Space Race** 

*Photo via Shutterstock*

### Related Stocks

- [MODD.US](https://longbridge.com/en/quote/MODD.US.md)
- [RKLB.US](https://longbridge.com/en/quote/RKLB.US.md)

## Related News & Research

- [Modular Medical Announces FDA Submission of Pivot Tubeless Insulin Patch Pump Enhancements | MODD Stock News](https://longbridge.com/en/news/291411093.md)
- [This Little-Known Software Stock Just Set a New All-Time High](https://longbridge.com/en/news/297539706.md)
- [Car owners want tech they can ignore](https://longbridge.com/en/news/297547365.md)
- [GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test](https://longbridge.com/en/news/297810359.md)
- [Take Two Interactive Software (TTWO) Could Be 15% Undervalued On GTA VI Ultimate Edition Demand](https://longbridge.com/en/news/297516598.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**